What is a certificate of analysis?

A certificate of analysis, or COA, records analytical results for an identified material or sample. It may include specifications, methods, test dates and an authorized review or release. Its usefulness depends on the quality of the underlying testing and its traceable connection to the material being discussed.

A COA is not a clinical approval, a guarantee of every possible quality attribute or proof of a product's effect in people. It also should not be mistaken for the complete laboratory record. Chromatograms, calculations, instrument records and method details may be needed to interpret a result.

Why does lot-specific testing matter?

Different production lots can have different impurity profiles or other attributes. A result from one lot does not establish the result for another. The lot identifier on a report should therefore connect clearly to the relevant material and sampling record.

Sampling itself matters. Testing a submitted sample is not the same as independently verifying every container in a batch. The laboratory's role, who selected the sample and any chain-of-custody limitations should be stated honestly. A third-party laboratory may be independent of manufacturing while still testing a sample supplied by the manufacturer or seller.

FDA's drug-manufacturing rules illustrate the importance of controls: they require specific identity testing of components and conditions for reliance on supplier analyses. These requirements apply within their regulatory scope; they should not be represented as proof that every research supplier follows them. 21 CFR 211.84.

Can a COA be fake?

Documents can be altered, misattributed or reused. Visual polish, a QR code or a laboratory logo does not establish authenticity. A sensible verification process compares the report with a record obtained through the laboratory's independently located official channel, where such verification is available.

Confirm that the laboratory actually issued the report and that the sample identifier, dates and results match. Do not assume that confirming the document also confirms the origin of the material or the contents of every container. Those are separate traceability questions.

What should a reader look for?

  • Exact material identity and sample or lot number.
  • Laboratory identity and report identifier.
  • Dates of receipt, testing and authorization, where applicable.
  • Test methods, result units and calculation basis.
  • Specifications or acceptance criteria, if a pass/fail conclusion is made.
  • Clear distinctions among identity, purity, content and contaminant testing.
  • Any sampling, method or scope limitations.

A missing test should be described as not reported, not assumed to have passed. FDA laboratory-record requirements provide a useful illustration of the detail needed to support pharmaceutical results, including methods, data and calculations. 21 CFR 211.194.

Takeaway: A credible COA is traceable evidence about defined tests on defined material. It is valuable, but it is not a substitute for manufacturing controls, representative sampling or clinical evidence.

Review flag: Do not claim AXON follows any specific process without current operational documentation.